London Cancer 

London Cancer is the integrated cancer system serving north east and central London and west Essex. We work with healthcare providers in these areas to deliver comprehensive and seamless cancer care to all patients from diagnosis, through treatment, to living with and beyond cancer. We also work to promote awareness of the signs and symptoms of cancer and uptake of cancer screening programmes, with the aim of enabling earlier diagnosis and prevention where possible.

London Cancer transferred to the UCLH Cancer Collaborative in September 2016 and our work is one of the four pillars of the Collaborative.

  • London Cancer Tumour Pathway Boards and Expert Reference Groups

    The London Cancer team support 20 Tumour Pathway Boards (TPBs) and Expert Reference Groups (ERGs) to help deliver and drive change to minimise variation of care received across all tumour types within north central and east London. The Boards meet quarterly and have representation from across the sector and from patients.

    A key output of our work is to develop a set of patient care ‘timed pathways’ for each cancer type. This is a document for each cancer type that specifies clear timelines by which appointments, diagnostics, clinical decision making and treatments should take place. They hold the potential to improve the patient journey for patients requiring care across a number of different hospitals.

    All three of the national Cancer Vanguard sites are working to achieve ‘timed pathways’ for patients and the next step is to roll out nationally agreed pathways across the NHS.

    For more information about London Cancer please contact kate.farrow@uclh.nhs.uk 

  • Multi-disciplinary team (MDT) improvement project

    All patients with a cancer diagnosis are looked after by a specialist multidisciplinary team (MDT). MDTs bring together clinicians, nurses and other staff with the necessary knowledge, skills and experience to ensure high quality diagnosis, treatment and care. The MDT meets weekly and the aim of their meeting is to offer high quality diagnosis and expert patient centred treatment recommendations.

    The MDT improvement project aims to learn from the best and make recommendations to improve the effectiveness of all MDTs. We are analysing the work of MDTs within north and east London and west Essex to address issues including:

    • Inefficiencies
    • IT issues, including e-referrals
    • Role of the MDT chair
    • Examples of best practice
    • Stratification of pathways to reduce meeting times and ensure more time is spent discussing ‘complex’ cases.

     

    For more information about the MDT improvement project please contact jacob.goodman@uclh.nhs.uk 

  • Macmillan Integrated Cancer Programme (MICa)

    London Cancer and Macmillan Cancer Support have forged a strong partnership over the past four years through the Macmillan Integrated Cancer (MICa)Programme. The MICa programme spans the cancer pathway from early diagnosis through to living with and beyond cancer – with patient experience and user involvement underpinning change and threaded throughout. The programme aims to:

    • Improve early diagnosis and patient experience and outcomes across the entire cancer pathway.
    • Empower individuals to be active participants in their health care and to support the transition and integration of their recovery into primary care. 

    The MICa programme will achieve its aims through:

    • Co-designing new models of cancer care, with a greater focus on presentation and earlier diagnosis, and parity of physical and mental health provision.
    • Putting innovation into practice to drive change at scale and pace.
    • Making recommendations to build a skilled workforce for the future.

    For more information about the MICa programme please contact sharon.cavanagh@uclh.nhs.uk